Scarica l'app Stockscreener
0.8999
0.63%
0.0099
Precedente Chiudi:
$0.89
Aprire:
$0.8913
Volume 24 ore:
34,301
Relative Volume:
0.22
Capitalizzazione di mercato:
$34.27M
Reddito:
$24.38M
Utile/perdita netta:
$-53.95M
Rapporto P/E:
-0.3643
EPS:
-2.47
Flusso di cassa netto:
$-23.31M
1 W Prestazione:
+1.63%
1M Prestazione:
-30.03%
6M Prestazione:
-58.73%
1 anno Prestazione:
-75.79%
Intervallo 1D:
$0.8913
$0.9846
Intervallo di 1 settimana:
$0.86
$0.9999
Portata 52W:
$0.85
$5.12
Elutia Inc Stock (ELUT) Company Profile
Nome
Elutia Inc
Settore
Industria
Telefono
240-247-1143
Indirizzo
12510 PROSPERITY DRIVE, SILVER SPRING
Confronta ELUT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.90 | 37.73M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
131.27 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.74 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
365.35 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.08 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.16 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-11-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-02 | Iniziato | Cowen | Outperform |
| 2020-11-02 | Iniziato | Piper Sandler | Overweight |
| 2020-11-02 | Iniziato | Truist | Buy |
Elutia Inc Borsa (ELUT) Ultime notizie
How Elutia Inc. stock responds to policy changes2025 Trading Recap & AI Forecasted Entry/Exit Points - newser.com
Elutia appoints medical tech veteran Guido Neels to board of directors - Investing.com Nigeria
Elutia Completes Sale of BioEnvelope to Boston Scientific - MSN
Applying big data sentiment scoring on Elutia Inc.Quarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Elutia Appoints Guido J. Neels To Board - citybiz
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors - The Manila Times
Elutia Inc. Appoints Guido J. Neels to Board of Directors, Strengthening Leadership in Medical Technology - Quiver Quantitative
Elutia appoints accomplished medtech veteran Guido J. Neels to board of directors - MarketScreener
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of Directors - TradingView
When is the best time to exit Elutia Inc.2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com
Backtesting results for Elutia Inc. trading strategies2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
What MACD signals say about Elutia Inc.2025 EndofYear Setup & Safe Swing Trade Setups - newser.com
Using portfolio simulators with Elutia Inc. includedMarket Growth Review & Detailed Earnings Play Strategies - newser.com
Combining machine learning predictions for Elutia Inc.Layoff News & Risk Controlled Stock Pick Alerts - newser.com
Tools to monitor Elutia Inc. recovery probabilityWatch List & High Accuracy Swing Entry Alerts - newser.com
Medical Device Innovator: Michelle LeRoux Williams - The Business Journals
SWK Holdings announces full repayment of Elutia loan following asset sale - Investing.com Canada
SWK Holdings announces full repayment of Elutia loan following asset sale By Investing.com - Investing.com Nigeria
Boston Sci closes Elutia deal, projects 10% growth through 2028 - BioWorld MedTech
SWK Holdings Announces Full Loan Repayment by Elutia - TipRanks
Elutia Closes BioEnvelope Business Sale To Boston Scientific For $88 Million - citybiz
Elutia announces closing of BioEnvelope business sale to Boston Scientific Corporation - MarketScreener
Elutia Announces Closing Of Bioenvelope Business Sale To Boston Scientific Corporation - TradingView
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - The Manila Times
Elutia Inc. Completes $88 Million Sale of BioEnvelope Business to Focus on NXT-41x Development for Breast Reconstruction - Quiver Quantitative
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - Benzinga
$88M Deal: Elutia Sells BioEnvelope to Boston Scientific, Targets $1.5B Breast Reconstruction Market - Stock Titan
Elutia (NASDAQ:ELUT) Stock Price Down 6.3% – Should You Sell? - Defense World
Will a bounce in Elutia Inc. offer an exit2025 Dividend Review & Community Consensus Trade Signals - newser.com
What drives Elutia Inc stock priceStock Valuation Metrics & Superior Capital Trading Plans - earlytimes.in
Elutia Inc Azioni (ELUT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Elutia Inc Azioni (ELUT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
0.14%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):